CIM
FOLD

CIM Investment Management’s Amicus Therapeutics FOLD Stock Holding History

CIM Investment Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32,305
Closed -$460K – 255
2025
Q4 		$460K Hold
32,305
– – 0.12% 139
2025
Q3 		$255K Sell
32,305
-34,808
-52% -$248K 0.07% 197
2025
Q2 		$511K Buy
67,113
+33,681
+101% +$217K 0.1% 175
2025
Q1 		$273K Sell
33,432
-801
-2% -$7.41K 0.06% 192
2024
Q4 		$322K Buy
34,233
+18,270
+114% +$190K 0.09% 183
2024
Q3 		$170K Hold
15,963
– – 0.05% 236
2024
Q2 		$158K Sell
15,963
-3,799
-19% -$39K 0.05% 233
2024
Q1 		$233K Hold
19,762
– – 0.07% 238
2023
Q4 		$280K Hold
19,762
– – 0.09% 212
2023
Q3 		$240K Hold
19,762
– – 0.09% 221
2023
Q2 		$248K Hold
19,762
– – 0.08% 221
2023
Q1 		$219K Buy
19,762
+680
+4% +$8.38K 0.08% 233
2022
Q4 		$233K Hold
19,082
– – 0.09% 203
2022
Q3 		$199K Hold
19,082
– – 0.09% 202
2022
Q2 		$205K Hold
19,082
– – 0.09% 204
2022
Q1 		$181K Sell
19,082
-2,222
-10% -$20.8K 0.06% 238
2021
Q4 		$246K Hold
21,304
– – 0.07% 245
2021
Q3 		$203K Hold
21,304
– – 0.06% 286
2021
Q2 		$205K Hold
21,304
– – 0.06% 287
2021
Q1 		$210K Buy
21,304
+11,567
+119% +$179K 0.07% 284
2020
Q4 		$225K Sell
9,737
-9,742
-50% -$199K 0.07% 253
2020
Q3 		$275K Buy
19,479
+281
+1% +$4.1K 0.1% 181
2020
Q2 		$290K Sell
19,198
-2,044
-10% -$24.9K 0.12% 172
2020
Q1 		$196K Sell
21,242
-20,000
-48% -$190K 0.1% 167
2019
Q4 		$402K Buy
+41,242
New +$378K 0.16% 135

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

CIM Investment Management's FOLD Position: Q1 2026 in Review

CIM Investment Management sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 32,305 shares — an estimated $460K sold.

CIM Investment Management first reported a position in FOLD in Q4 2019 and held it in 25 quarters. The position peaked at $511K in Q2 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • CIM Investment Management reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • CIM Investment Management sold 32,305 Amicus Therapeutics shares in Q1 2026, an estimated $460K.
  • CIM Investment Management first reported a position in Amicus Therapeutics in Q4 2019 and held it in 25 quarters.
  • CIM Investment Management's Amicus Therapeutics position peaked at $511K in Q2 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on CIM Investment Management's 13F filing for Q1 2026, filed 19 May 2026.